Enhancing the efficacy of Ara-C through conjugation with PAMAM dendrimer and linear PEG: A comparative study

Biomacromolecules

Volumn 14, Issue 3, 2013, Pages 801-810

  Sk, Ugir Hossain ^a   Kambhampati, Siva P ^a,b   Mishra, Manoj K ^a,b   Lesniak, Wojciech G ^a,b   Zhang, Fan ^a,b   Kannan, Rangaramanujam M ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE MYELOID LEUKEMIA; COVALENT ATTACHMENT; DRUG RELEASE KINETICS; HUMAN ADENOCARCINOMA; HYDROXYL-TERMINATED; INACTIVE METABOLITES; MALDI-TOF MASS SPECTROMETRY; PHYSICOCHEMICAL PROPERTY;

DRUG PRODUCTS; MASS SPECTROMETRY;

DENDRIMERS;

CYTARABINE; DENDRIMER; DRUG CARRIER; HYDROXYL GROUP; MACROGOL; PHOSPHATE BUFFERED SALINE; POLYAMIDOAMINE;

ARTICLE; CANCER INHIBITION; CARBON NUCLEAR MAGNETIC RESONANCE; CARCINOMA CELL; COMPARATIVE STUDY; CONTROLLED STUDY; COVALENT BOND; DEPROTECTION REACTION; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG STABILITY; DRUG SYNTHESIS; GEL PERMEATION CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PLASMA; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SUSTAINED DRUG RELEASE; SYNTHESIS;

ARABINOFURANOSYLURACIL; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTARABINE; CYTIDINE DEAMINASE; DENDRIMERS; HUMANS; HYDROGEN-ION CONCENTRATION; LEUKEMIA, MYELOID, ACUTE; MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; PHYSICOCHEMICAL PHENOMENA; POLYETHYLENE GLYCOLS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84874875091     PISSN: 15257797     EISSN: 15264602     Source Type: Journal    
DOI: 10.1021/bm3018615     Document Type: Article

References (45)

1. Lauer, S. J.; Pinkel, D.; Buchanan, G. R.; Sartain, P.; Cornet, J. M.; Krance, R.; Borella, L. D.; Camitta, B. M. Cancer 1987, 60, 2366-2371
2. Bishop, J. F. Semin. Oncol. 1997, 24, 57-69
3. Galmarini, C. M.; Mackey, J. R.; Dumontet, C. Lancet Oncol. 2002, 3, 415-424
4. Lindner, L. H.; Ostermann, H.; Hiddemann, W.; Kiani, A.; Würfel, M.; Illmer, T.; Karsch, C.; Platzbecker, U.; Ehninger, G.; Schleyer, E. Int. J. Hematol. 2008, 88, 381-386
5. Muus, P.; Haanen, C.; Raijmakers, R.; de Witte, T.; Salden, M.; Wessels, J. Semin. Oncol. 1987, 14, 238-244
6. Marsh, J. H.; Kreis, W.; Barile, B.; Akerman, S.; Schulman, P.; Allen, S. L.; DeMarco, L. C.; Budman, D. R. Cancer Chemother. Pharmacol. 1990, 31, 481-484
7. Mangravite, L. M.; Badagnani, I.; Giacomini, K. M. Eur. J. Pharmacol. 2003, 479, 269-281
8. Onishi, H.; Seno, Y.; Pithayanukul, P.; Nagai, T. Drug Des. Delivery 1991, 7, 139-145
9. Aoshima, M.; Tsukagoshi, S.; Sakurai, Y.; Oh-ishi, J. I.; Ishida, T. Cancer Res. 1977, 37, 2481-2486
10. Wipf, P.; Li, W.; Sekhar, V. Bioorg. Med. Chem. Lett. 1991, 1, 745-750
11. Ichikawa, H.; Onishi, H.; Takahata, T.; Machida, Y.; Nagai, T. Drug Des. Discovery 1993, 10, 343-353
12. Sezaki, H.; Takakura, Y.; Hashida, M. Adv. Drug Delivery Rev. 1989, 3, 247-256
13. Duncan, R. Anticancer Drugs 1992, 3, 175-210
14. Choe, Y. H.; Conover, C. D.; Wu, D.; Royzen, M.; Greenwald, R. B. J. Controlled Release 2002, 79, 41-53
15. Schiavon, O.; Pasut, G.; Moro, S.; Orsolini, P.; Guiotto, A.; Veronese, F. M. Eur. J. Med. Chem. 2004, 39, 123-133
16. Svenson, S.; Tomalia, D. A. Adv. Drug Delivery Rev. 2005, 57, 2106-2129
17. Lee, C. C.; Mackay, J. A.; Frechet, J. M.; Szoka, F. C. Nat. Biotechnol. 2005, 23, 1517-1526
18. Menjoge, A. R.; Kannan, R. M.; Tomalia, D. A. Drug Discovery Today 2010, 15, 171-185
19. Patri, A. K.; Kukowska-Latallo, J. F.; Baker, J. R., Jr. Adv. Drug Delivery Rev. 2005, 57, 2203-2214
20. Gurdag, S.; Khandare, J.; Stapels, S.; Matherly, L. H.; Kannan, R. M. Bioconjugate Chem. 2006, 17, 275-283
21. Khandare, J.; Kolhe, P.; Pillai, O.; Kannan, S.; Lieh-Lai, M.; Kannan, R. M. Bioconjugate Chem. 2005, 16, 330-337
22. Kolhe, P.; Khandare, J.; Pillai, O.; Kannan, S.; Lieh-Lai, M.; Kannan, R. M. Biomaterials 2006, 27, 660-669
23. McCarthy, T. D.; Karellas, P.; Henderson, S. A.; Giannis, M.; O'Keefe, D. F.; Heery, G.; Paull, J. R.; Matthews, B. R.; Holan, G. Mol. Pharm. 2005, 2, 312-318
24. Clayton, R.; Hardman, J.; LaBranche, C. C.; McReynolds, K. D. Bioconjugate Chem. 2011, 22, 2186-97
25. Talanov, V. S.; Regino, C. A. S.; Kobayashi, H.; Bernardo, M.; Choyke, P. L.; Brechbiel, M. W. Nano Lett. 2006, 6, 1459-1463
26. Kirkpatrick, G. J.; Plumb, J. A.; Sutcliffe, O. B.; Flint, D. J.; Wheate, N. J. J. Inorg. Biochem. 2011, 105, 1115-1122
27. Zhang, Y.; Thomas, T. P.; Lee, K. H.; Li, M.; Zong, H.; Desai, A. M.; Kotlyar, A.; Huang, B.; Holl, M. M.; Baker, J. R., Jr. Bioorg. Med. Chem. 2011, 19, 2557-64
28. Vijayalakshmi, N.; Ray, A.; Malugin, A.; Ghandehari, H. Bioconjugate Chem. 2010, 21, 1804-1810
29. Lesniak, W. G.; Kariapper, M. S. T.; Nair, B. M.; Balogh, L. P.; Khan, M. K. Bioconjugate Chem. 2007, 18, 1148-1154
30. Lesniak, W.; Shi, X.; Bielinska, A. U.; Janczak, K. W.; Sun, K.; Baker, J. R., Jr.; Balogh, L. P. Nano Lett. 2005, 5, 2123-2130
31. Khandare, J. J.; Jayant, S.; Singh, A.; Chandna, P.; Wang, Y.; Vorsa, N.; Minko, T. Bioconjugate Chem. 2006, 17, 1464-72
32. Sunoqrot, S.; Bae, J. W.; Pearson, R. M.; Shyu, K.; Liu, Y.; Kim, D. H.; Hong, S. Biomacromolecules 2012, 13, 1223-1230
33. Bosnjakovic, A.; Mishra, M. K.; Ren, W.; Kurtoglu, Y. E.; Shi, T.; Fan, D.; Kannan, R. M. Nanomedicine 2011, 7, 284-94
34. Mishra, M. K.; Kotta, K.; Hali, M.; Wykes, S.; Gerard, H. C.; Hudson, A. P.; Whittum-Hudson, J. A.; Kannan, R. M. Nanomedicine 2011, 7, 935-44
35. Gillies, E. R.; Frechet, J. M. J. Drug Discovery Today 2005, 10, 35-43
36. Chauhan, A. S.; Sridevi, S.; Chalasani, K. B.; Jain, A. K.; Jain, S. K.; Jain, N. K.; Diwan, P. V. J. Controlled Release 2003, 90, 335-343
37. Jain, N. K.; Gupta, U. Expert Opin. Drug Metab. Toxicol. 2008, 4, 1035-1052
38. Kurtoglu, Y. E.; Mishra, M. K.; Kannan, S.; Kannan, R. M. Int. J. Pharm. 2010, 384, 189-194
39. Lee, C. C.; Gillies, E. R.; Fox, M. E.; Guillaudeu, S. J.; Fréchet, J. M.; Dy, E. E.; Szoka, F. C. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 16649-54
40. Kannan, S.; Dai, H.; Navath, R. S.; Balakrishnan, B.; Jyoti, A.; Janisse, J.; Romero, R.; Kannan, R. M. Sci. Transl. Med. 2012, 4 (130) 130ra46
41. Iezzi, R.; Guru, B. R.; Glybina, I. V.; Mishra, M. K.; Kennedy, A.; Kannan, R. M. Biomaterials 2012, 33, 979-88
42. Dai, H.; Navath, R. S.; Balakrishnan, B.; Guru, B. R.; Mishra, M. K.; Romero, R.; Kannan, R. M.; Kannan, S. Nanomedicine 2010, 5, 1317-1329
43. Bazzanini, R.; Gouy, M.; Peyrottes, S.; Gosselin, G.; Périgaud, C.; Manfredini, S. Nucleosides, Nucleotides Nucleic Acids 2005, 24, 1635-1649
44. Navath, R. S.; Kurtoglu, Y. E.; Wang, B.; Kannan, S.; Romero, R.; Kannan, R. M. Bioconjugate Chem. 2008, 19, 2446-55
45. Perumal, O. P.; Inapagolla, R.; Kannan, S.; Kannan, R. M. Biomaterials 2008, 29, 3469-3476